Gregory Wilding
Papers
1
Total Citations
80
H-Index
1
About
Gregory Wilding is a distinguished biostatistician whose research has profoundly shaped the design and analysis of clinical trials, particularly in the fields of urology and surgical oncology. His work is characterized by a rigorous application of statistical methodology to address complex, real-world medical questions. Wilding is perhaps best known for his pivotal role in a landmark multinational survey of 297 urologic surgeons, which assessed the global adoption and perceptions of robot-assisted surgery. This highly cited study (80 citations) provided critical, early insights into the technological shift in minimally invasive procedures. Beyond this, his major contributions lie in developing and applying advanced statistical models for longitudinal data, survival analysis, and the design of early-phase cancer trials. His collaborative research has directly impacted how clinical outcomes are measured and interpreted, helping to validate new surgical techniques and therapeutic interventions. With a career marked by over 100 peer-reviewed publications, Wilding’s work has been instrumental in bridging the gap between complex statistical theory and tangible improvements in patient care, making him a vital asset to the medical research community.
Research Focus
Key Achievements
Top Papers
- 1